Pfizer : PFE

All Pfizer Articles

1491 Articles

Vandita Jadeja | Apr 17, 2026 at 10:22 AM EDT

AbbVie vs. Pfizer: One Pharma Dividend Has a Moat — The Other Is Praying for a Pipeline Hit

AbbVie (NYSE:ABBV | ABBV Price Prediction) and Pfizer (NYSE:PFE) both reported fourth quarter earnings in early February. AbbVie posted record…

Lee Jackson | Apr 16, 2026 at 7:57 AM EDT

Here Are Thursday’s Top Wall Street Analyst Research Calls: Autoliv, CoreWeave, Corning, Dicks Sporting Goods, Federated Hermes, Gitlab, PayPal, Pfizer, Okta, and More

Pre-Market Stock Futures: The futures are trading modestly higher after a wild Wednesday that saw the Nasdaq explode higher to…

Drew Wood | Apr 14, 2026 at 9:00 AM EDT

Build a Six Figure Dividend Stream With Four Blue Chip Names and $2 Million

Two million dollars in four household-name dividend payers can generate between $132,000 and $146,000 in annual income. That is the…

Drew Wood | Apr 14, 2026 at 8:00 AM EDT

Four Tickers That Turn $1 Million Into $60,000 of Annual Income

A million dollars sounds like enough to retire on. Whether it actually is depends entirely on what you make it…

Vandita Jadeja | Apr 6, 2026 at 12:15 PM EDT

High Yield vs. Sustainable Growth: Why AbbVie’s Dividend Beats Pfizer’s Despite the Lower Payout

Pharmaceutical companies AbbVie (NYSE:ABBV | ABBV Price Prediction) and Pfizer (NYSE:PFE) both reported fourth-quarter earnings in early February, revealing two…

Michael Williams | Mar 28, 2026 at 7:15 AM EDT

PPH ETF: Drug Pricing Policy and Eli Lilly Concentration Are the Two Risks to Watch in 2026

VanEck Pharmaceutical ETF (NYSEARCA:PPH) exists to give investors broad exposure to the global pharmaceutical industry without the binary risk of…

Trey Thoelcke | Mar 26, 2026 at 7:55 AM EDT

Income Investors Face a Hard Truth About Pfizer’s Payout Safety

Pfizer (NYSE: PFE | PFE Price Prediction) is one of the most widely held dividend stocks among retirement investors. The…

Joey Frenette | Mar 25, 2026 at 12:23 PM EDT

This 6.5%‑Yielding Dividend Payer is Sitting on a Breakthrough Investors Haven’t Priced In

It’s rare to get such a massive high-yielder that’s also positioning itself for long-term growth. Of course, shares of Pfizer…

Joel South | Mar 24, 2026 at 10:52 AM EDT

Pfizer Could Hit $36 by Year-End as Analysts See 2-to-1 Payoff on Key Prostate Cancer Trial

Pfizer (NYSE:PFE | PFE Price Prediction) has quietly built momentum in 2026, with shares up 6.61% year-to-date and 2.70% over…

Lee Jackson | Mar 18, 2026 at 7:19 AM EDT

20 Years on Wall Street Taught Me: Big Dividend Healthcare Stocks Never Go Out of Style

After a career spanning two decades at Bear Stearns, Lehman Brothers, and Morgan Stanley, I gained an institutional perspective on…

Lee Jackson | Feb 12, 2026 at 8:00 AM EST

Here Are Thursday’s Top Wall Street Analyst Research Calls: BP Plc., Borg Warner, Generac, Kraft-Heinz, MercadoLibre, Pfizer, Shopify, Valvoline, and More

Pre-Market Stock Futures: Futures are trading higher after a wild Wednesday that saw the market rally hard on the open…

Vandita Jadeja | Feb 11, 2026 at 10:00 AM EST

Ultra-High Yield Dividend Stocks Yielding More Than 5%

Choosing the right investment vehicles can ensure steady income and wealth generation. Growth stocks are often considered to be an…

David Moadel | Feb 6, 2026 at 3:37 PM EST

3 High-Yield Dividend Stocks Perfect For Retirees

What does a successful retirement look like? If it means financial security through steady income sources, then you can get…

Lee Jackson | Feb 6, 2026 at 7:45 AM EST

5 High-Yield Stocks (6%-8%) Every Retiree Should Consider Now

These five quality stocks come with at least a 6% dividend and are likely to raise their dividends year in…

Vandita Jadeja | Jan 31, 2026 at 8:28 PM EST

Passive Income Investors Will Love These Cheap Dividend Stocks

Passive income can help secure your retirement, but building a dependable income is not easy. You must be able to…

1 2 3 4 5 … 100

Pfizer : PFE

All Pfizer Articles

AbbVie vs. Pfizer: One Pharma Dividend Has a Moat — The Other Is Praying for a Pipeline Hit

Here Are Thursday’s Top Wall Street Analyst Research Calls: Autoliv, CoreWeave, Corning, Dicks Sporting Goods, Federated Hermes, Gitlab, PayPal, Pfizer, Okta, and More

Build a Six Figure Dividend Stream With Four Blue Chip Names and $2 Million

Four Tickers That Turn $1 Million Into $60,000 of Annual Income

High Yield vs. Sustainable Growth: Why AbbVie’s Dividend Beats Pfizer’s Despite the Lower Payout

PPH ETF: Drug Pricing Policy and Eli Lilly Concentration Are the Two Risks to Watch in 2026

Income Investors Face a Hard Truth About Pfizer’s Payout Safety

This 6.5%‑Yielding Dividend Payer is Sitting on a Breakthrough Investors Haven’t Priced In

Pfizer Could Hit $36 by Year-End as Analysts See 2-to-1 Payoff on Key Prostate Cancer Trial

20 Years on Wall Street Taught Me: Big Dividend Healthcare Stocks Never Go Out of Style

Here Are Thursday’s Top Wall Street Analyst Research Calls: BP Plc., Borg Warner, Generac, Kraft-Heinz, MercadoLibre, Pfizer, Shopify, Valvoline, and More

Ultra-High Yield Dividend Stocks Yielding More Than 5%

3 High-Yield Dividend Stocks Perfect For Retirees

5 High-Yield Stocks (6%-8%) Every Retiree Should Consider Now

Passive Income Investors Will Love These Cheap Dividend Stocks

Jim Cramer: CoreWeave’s Backlog ‘May Be Much Greater’ Than Wall Street Thinks

Google, SpaceX, Microsoft, and Amazon Are About to Spend ‘Twice the Entire U.S. Defense Budget’ on AI

Amazon’s CEO: AI Growth Is Dwarfing Everything We’ve Seen Before.

SECURE 2.0 Changes Force High Earners to Rethink 401(k) Strategy. Here's the Math.

The RFK Jr. Medicare AI Program Already Denying Seniors Care in 6 States

Procter & Gamble vs. Colgate-Palmolive: One Dividend Giant Stands Above the Rest

Jim Cramer: CoreWeave’s Backlog ‘May Be Much Greater’ Than Wall Street Thinks

Pfizer : PFE

All Pfizer Articles

AbbVie vs. Pfizer: One Pharma Dividend Has a Moat — The Other Is Praying for a Pipeline Hit

Here Are Thursday’s Top Wall Street Analyst Research Calls: Autoliv, CoreWeave, Corning, Dicks Sporting Goods, Federated Hermes, Gitlab, PayPal, Pfizer, Okta, and More

Build a Six Figure Dividend Stream With Four Blue Chip Names and $2 Million

Four Tickers That Turn $1 Million Into $60,000 of Annual Income

High Yield vs. Sustainable Growth: Why AbbVie’s Dividend Beats Pfizer’s Despite the Lower Payout

PPH ETF: Drug Pricing Policy and Eli Lilly Concentration Are the Two Risks to Watch in 2026

Income Investors Face a Hard Truth About Pfizer’s Payout Safety

This 6.5%‑Yielding Dividend Payer is Sitting on a Breakthrough Investors Haven’t Priced In

Pfizer Could Hit $36 by Year-End as Analysts See 2-to-1 Payoff on Key Prostate Cancer Trial

20 Years on Wall Street Taught Me: Big Dividend Healthcare Stocks Never Go Out of Style

Here Are Thursday’s Top Wall Street Analyst Research Calls: BP Plc., Borg Warner, Generac, Kraft-Heinz, MercadoLibre, Pfizer, Shopify, Valvoline, and More

Ultra-High Yield Dividend Stocks Yielding More Than 5%

3 High-Yield Dividend Stocks Perfect For Retirees

5 High-Yield Stocks (6%-8%) Every Retiree Should Consider Now

Passive Income Investors Will Love These Cheap Dividend Stocks

Jim Cramer: CoreWeave’s Backlog ‘May Be Much Greater’ Than Wall Street Thinks

Google, SpaceX, Microsoft, and Amazon Are About to Spend ‘Twice the Entire U.S. Defense Budget’ on AI

Amazon’s CEO: AI Growth Is Dwarfing Everything We’ve Seen Before.

Featured Reads

SECURE 2.0 Changes Force High Earners to Rethink 401(k) Strategy. Here's the Math.

The RFK Jr. Medicare AI Program Already Denying Seniors Care in 6 States